Warning: The NCBI web site requires JavaScript to function. more...

Full Report

Format

Full Report
Summary (Text)
Summary (XML)

Send to:

Choose Destination

File
Clipboard
Collections

Bladder papillary urothelial carcinoma

MedGen UID:: 309552
•Concept ID:: C1518882
•: Neoplastic Process

Synonyms:	Bladder Papillary Urothelial Carcinoma; bladder papillary urothelial carcinoma; bladder urothelial papillary carcinoma; urinary bladder papillary transitional cell carcinoma; Urothelial Papillary Carcinoma of the Bladder; urothelial papillary carcinoma of the bladder

Monarch Initiative:	MONDO:0004056

Definition

An invasive or non-invasive papillary urothelial carcinoma of the urinary bladder. It is classified as low or high-grade. [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVBladder papillary urothelial carcinoma

Disorder by Site
- Disorder of the genitourinary system
  - Urinary system disorder
    - Urinary bladder disorder
      - Bladder neoplasm
        Bladder papillary urothelial neoplasm
        Bladder papillary urothelial carcinoma
        Bladder Non-Invasive Papillary Urothelial Carcinoma
        Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade
        Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade
        Stage 0a Bladder Cancer AJCC v8
        Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
        Micropapillary variant infiltrating bladder urothelial carcinoma
        Metastatic Bladder Micropapillary Urothelial Carcinoma

Professional guidelines

PubMed

APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.

Zhao S, Li Y, Xu J, Shen L
Neurol Res 2024 Mar;46(3):227-242. Epub 2024 Jan 22 doi: 10.1080/01616412.2023.2287340. PMID: 38007705

Immune checkpoints inhibitors in the management of high-risk non-muscle-invasive bladder cancer. A scoping review.

García-Perdomo HA, Sánchez AL, Spiess PE
Urol Oncol 2022 Sep;40(9):409.e1-409.e8. Epub 2022 Feb 26 doi: 10.1016/j.urolonc.2022.02.003. PMID: 35232680

Optimal treatment of non-muscle invasive urothelial carcinoma including perioperative management revisited.

Pagano MJ, Badalato G, McKiernan JM
Curr Urol Rep 2014 Nov;15(11):450. doi: 10.1007/s11934-014-0450-1. PMID: 25234184

Recent clinical studies

Diagnosis

Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and Prostate Adenocarcinoma Diagnosed in One Procedure.

Deng F, Kong MX, Lai J
Anticancer Res 2022 Jul;42(7):3601-3605. doi: 10.21873/anticanres.15847. PMID: 35790255

Clinical prediction guides

Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and Prostate Adenocarcinoma Diagnosed in One Procedure.

Deng F, Kong MX, Lai J
Anticancer Res 2022 Jul;42(7):3601-3605. doi: 10.21873/anticanres.15847. PMID: 35790255

Supplemental Content

Table of contents

Clinical resources

ClinicalTrials.gov

Practice guidelines

PubMed
See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
Bookshelf
See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

Consumer resources

MedlinePlus

Reviews

Related information

PMC Articles
Related information in PubMed Central Links
PubMed
Related literature resources in PubMed

Recent activity

Clear Turn Off Turn On

Bladder papillary urothelial carcinoma
Bladder papillary urothelial carcinoma

MedGen

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...